v3.26.1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities        
Net income $ 6,766 $ 6,591 $ 14,234 $ 12,655
Adjustments to reconcile net income to net cash provided by operating activities        
Unrealized gain on loans receivable, at fair value (402) (978) (872) (1,924)
Unrealized loss on secured financings, at fair value 134 258 290 509
Unrealized (gain) loss on derivative instruments, net 313 2,532 (542) 3,515
Loss (gain) on foreign currency translation (58) (2,390) 699 (3,585)
Financing fees 41 193 220 354
Amortization of share grants     30 30
Change in assets and liabilities        
Increase in accrued interest receivable     (495) (569)
Decrease (increase) in prepaid assets     636 (257)
(Decrease) increase in due to advisor     (1,122) 627
(Decrease) increase in interest payable     (142) 139
(Decrease) increase in other liabilities     (279) 298
Net cash provided by operating activities     12,657 11,792
Cash flows from investing activities        
Loan origination and funding activities     (234,690) (200,176)
Repayment of loans receivable     98,887 19,500
Net cash used in investing activities     (135,803) (180,676)
Cash flows from financing activities        
Borrowings under secured financings     190,524 197,334
Financing fees paid     (850) (354)
Repayments of secured financings     (115,169) (60,938)
Contributions received from common shares issued     73,794 37,175
Subscriptions received in advance     2,537 5,165
Repurchases of common shares (6,400) (300) (7,823) (255)
Offering costs     (1,185) (333)
Distributions     (18,331) (9,802)
Net cash provided by financing activities     123,497 167,992
Effect of exchange rate changes on cash balances     (1,161) 18
Net change in cash and cash equivalents and restricted cash     (810) (874)
Cash and cash equivalents and restricted cash, beginning of period 8,062 10,507 8,872 11,381
Cash and cash equivalents and restricted cash, end of period 8,062 10,507 8,062 10,507
Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets:        
Cash and cash equivalents 5,525 5,342 5,525 5,342
Restricted cash 2,537 5,165 2,537 5,165
Total cash and cash equivalents and restricted cash 8,062 10,507 8,062 10,507
Supplemental disclosure of cash flow information:        
Cash paid for interest     30,572 22,258
Non-cash financing activities:        
Accrued shareholder servicing fees due to affiliate     1,916 1,526
Accrued offering costs due to affiliate     (240) 68
Distributions payable $ 2,331 $ 1,911 2,331 1,911
Distribution reinvestment     8,326 4,622
Allocation to redeemable non-controlling interests     $ (102) $ 424